Journal for ImmunoTherapy of Cancer (Nov 2021)

742 Multi-armed myxoma virus induces potent anti-tumor responses in vitro and in vivo

Lina Franco,
Ana de Matos,
Mario Abrantes,
Zachary Tacner,
Leslie Sharp,
Wazir Abdullahi,
Christopher Fraser,
Heather Hrach,
Nicole Grigaitis

Affiliations

Lina Franco: OncMyx Therapeutics, Phoenix, AZ, USA
Ana de Matos: OncMyx Therapeutics, Phoenix, AZ, USA
Mario Abrantes: OncMyx Therapeutics, Phoenix, AZ, USA
Zachary Tacner: OncMyx Therapeutics, Phoenix, AZ, USA
Leslie Sharp: OncMyx Therapeutics, Phoenix, AZ, USA
Wazir Abdullahi: OncoMyx Therapeutics, Phoenix, AZ, United States
Christopher Fraser: OncoMyx Therapeutics, Phoenix, AZ, United States
Heather Hrach: OncoMyx Therapeutics, Phoenix, AZ, United States
Nicole Grigaitis: OncoMyx Therapeutics, Phoenix, AZ, United States

DOI: https://doi.org/10.1136/jitc-2021-SITC2021.742
Journal volume & issue: Vol. 9, no. Suppl 2

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal